Sale!

PTCHD1 Gene Autism Susceptibility X-Linked Type 4 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PTCHD1 Gene Autism Susceptibility X-Linked Type 4 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PTCHD1 gene, which have been linked to an increased risk of autism spectrum disorders (ASD), particularly in males due to its X-linked inheritance pattern. This test plays a crucial role in understanding the genetic predisposition of an individual to ASD, enabling early intervention and personalized management plans. With a cost of 4400 AED, the test offers families and healthcare providers valuable insights into the genetic factors contributing to autism, facilitating more targeted therapeutic strategies and support for affected individuals.

Description

PTCHD1 Gene Autism susceptibility X-linked type 4 Genetic Test

Components: PTCHD1 Gene Autism susceptibility X-linked type 4 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PTCHD1 Gene Autism susceptibility, X-linked type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTCHD1 Gene Autism susceptibility, X-linked type 4.

Test Details: The PTCHD1 gene is located on the X chromosome and is involved in brain development and function. Mutations in this gene have been associated with an increased risk for autism spectrum disorder (ASD), specifically in males. NGS (next-generation sequencing) genetic testing involves analyzing multiple genes at once to identify potential mutations or variants that may be contributing to a patient’s condition. In the case of autism, NGS testing may be used to identify mutations in the PTCHD1 gene, as well as other genes associated with ASD. X-linked type 4 refers to the inheritance pattern of the gene mutation, meaning that it is located on the X chromosome and can be passed down from a carrier mother to her son. Females can also be carriers of X-linked mutations, but typically do not exhibit the same level of symptoms as males. Overall, NGS genetic testing for the PTCHD1 gene can provide valuable information for families and clinicians in identifying potential genetic causes of ASD and informing treatment and management strategies.

Test Name	PTCHD1 Gene Autism susceptibility X-linked type 4 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for PTCHD1 Gene Autism susceptibility, X-linked type 4 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PTCHD1 Gene Autism susceptibility, X-linked type 4
Test Details	The PTCHD1 gene is located on the X chromosome and is involved in brain development and function. Mutations in this gene have been associated with an increased risk for autism spectrum disorder (ASD), specifically in males. NGS (next-generation sequencing) genetic testing involves analyzing multiple genes at once to identify potential mutations or variants that may be contributing to a patient’s condition. In the case of autism, NGS testing may be used to identify mutations in the PTCHD1 gene, as well as other genes associated with ASD. X-linked type 4 refers to the inheritance pattern of the gene mutation, meaning that it is located on the X chromosome and can be passed down from a carrier mother to her son. Females can also be carriers of X-linked mutations, but typically do not exhibit the same level of symptoms as males. Overall, NGS genetic testing for the PTCHD1 gene can provide valuable information for families and clinicians in identifying potential genetic causes of ASD and informing treatment and management strategies.